Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yonghe Medical Group CoHKSE:02279 +5.51%84 Net Margin % is 7.70% as of Jun. 2026, which is 120% above its 10-year median of 3.50. GuruFocus rates HKSE:02279 with a GF Score™ of 84/100 and a GF Value™ of HK$2.01 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Yonghe Medical Group Co ranks better than 56.78% on this metric.
The historical rank and industry rank for Yonghe Medical Group Co's Net Margin % or its related term are showing as below:
HKSE:02279'
s Net Margin % Range Over the Past 10 Years
Min: -30.74 Med: 3.5 Max: 9.97
Current: 6.33
HKSE:02279's Net Margin % is ranked better than 56.78% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 2.945
vs HKSE:02279: 6.33
Yonghe Medical Group Co (HKSE:02279) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Yonghe Medical Group Co Net Margin % Related Terms
Yonghe Medical Group Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02279 vs HCA, THC, DVA: Net Margin % Comparison
For the Medical Care Facilities subindustry, Yonghe Medical Group Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yonghe Medical Group Co Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yonghe Medical Group Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Yonghe Medical Group Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yonghe Medical Group Co (HKSE:02279) has a Net Margin % of 7.70% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Yonghe Medical Group Co and its competitors. This is 120% above median its historical median of 3.50. According to the industry distribution chart, Yonghe Medical Group Co ranks #287 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 43.2%.
Is Yonghe Medical Group Co's Net Margin % too high?
Yonghe Medical Group Co's current Net Margin % of 7.70% is 120% above median its 10-year median of 3.50. The Healthcare Providers & Services industry median Net Margin % is 2.95. Yonghe Medical Group Co's value of 7.70% is 161.5% above this industry median. Based on the distribution chart, Yonghe Medical Group Co ranks #287 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Yonghe Medical Group Co has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yonghe Medical Group Co's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Yonghe Medical Group Co ranks #287 out of 664 companies for Net Margin %. This puts Yonghe Medical Group Co in the upper half of its industry. The industry median Net Margin % is 2.95. Yonghe Medical Group Co's value of 7.70% is 161.5% above this benchmark. While the company's 10-year median is 3.50 vs. the industry median of 2.95, Yonghe Medical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.95, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yonghe Medical Group Co's current Net Margin % of 7.70% is 161.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Yonghe Medical Group Co and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yonghe Medical Group Co's current Net Margin % is 7.70%, which is 120% above median its own 10-year median of 3.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yonghe Medical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Yonghe Medical Group Co (HKSE:02279) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$2.01, compared to a current price of HK$2.49 — trading 23.9% above its estimated fair value. The current Net Margin % is 7.70%, which is 120% above median its 10-year median of 3.50 and 161.5% above the Healthcare Providers & Services industry median of 2.95. Yonghe Medical Group Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Yonghe Medical Group Co (HKSE:02279), the current Net Margin % is 7.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yonghe Medical Group Co (HKSE:02279) Overvalued in 2026?
Based on GuruFocus' analysis, Yonghe Medical Group Co stock appears to be overvalued.
The current stock price of HK$2.49 is trading 23.9% above its estimated GF Value™ of HK$2.01.
GuruFocus considers Yonghe Medical Group Co to be Modestly Overvalued.
Key valuation signals for HKSE:02279:
Net Margin %: 7.70% (120% above median its 10-year median of 3.50)
GF Value™: HK$2.01 vs. price of HK$2.49 (23.9% above fair value)
Industry Position: 161.5% above the Healthcare Providers & Services median (#287 of 664)
No single metric tells the full story. See the HKSE:02279 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. The company is principally engaged in the provision of hair transplant services. The company generated the majority of its revenue from hair transplant services. The company offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
84GF Score
Get the complete analysis for HKSE:02279
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02279 has been successfully added to your 
